• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Alterra.ai and MyMO Launch a Chatbot That can Answer Questions on the Coronavirus Outbreak

Share:

March 23, 2020

The COVID Q&A bot answers questions on the coronavirus symptoms, prevention, and treatment, among other things. It helps people concerned about the coronavirus outbreak to quickly get answers to their burning questions.

The bot relies on the information from the Centers for Disease Control and Prevention (CDC) (CDC) and the World Health Organization (WHO). It is available at the developer’s website https://next.alterra.ai/covid-qna-bot and on the Facebook Messenger platform https://m.me/AlterraCovidQnABot.

The bot is available to medical centers, health insurers, government organizations and businesses. Any interested company or organization can customize the bot with its own local or internal information and add it to its website.

For example, as companies switch to remote work as a result of COVID-19 concerns, they can use Alterra’s platform to create custom Q&A bots for their employees to provide answers to quarantine-related questions like work from home policy, suspending international travel, events cancellation, etc. Companies that use Slack can add the COVID Q&A bot to their workspaces, so their employees can get answers right in Slack.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The bot is built on top of a proprietary NLP Engine developed by Alterra.ai, a California-based Deep Learning NLP startup, with the help of MyMO, a patient communications and healthcare operations automation company, who brought in its extensive knowledge of the healthcare industry and counts NewYork-Presbyterian, Mount Sinai and several other major hospitals as its customers.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Wedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need for Testing Compounded Medications for Animal HealthWedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need for Testing Compounded Medications for Animal Health
  • Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating An Innovative Leader in Endocrinology and Rare DiseasesXeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma Plc in Stock and CVR Transaction, Creating An Innovative Leader in Endocrinology and Rare Diseases
  • Inizio Acquires Evolution Road, Bolstering Evoke’s Digital Innovation and Omnichannel OfferingInizio Acquires Evolution Road, Bolstering Evoke’s Digital Innovation and Omnichannel Offering
  • Amino Health Secures $80M for Healthcare Guidance PlatformAmino Health Secures $80M for Healthcare Guidance Platform
  • Carthamin Market 2020: COVID Impact, Industrial Growth, Regional Analysis, Trends and Forecasts 2024Carthamin Market 2020: COVID Impact, Industrial Growth, Regional Analysis, Trends and Forecasts 2024
  • Virtual Clinical Trials: A New Model for Patient EngagementVirtual Clinical Trials: A New Model for Patient Engagement
  • Amedica Announces Agreement To Sell Spine Business To CTL MedicalAmedica Announces Agreement To Sell Spine Business To CTL Medical
  • Syneos Health Acquires StudyKIKAcquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention and DiversitySyneos Health Acquires StudyKIKAcquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention and Diversity

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications